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Leuven, BelgiumABSTRACT The SERCA2a isoform of the sarco/endoplasmic reticulum Ca2þ pumps is specifically expressed in the heart,
whereas SERCA2b is the ubiquitously expressed variant. It has been shown previously that replacement of SERCA2a by
SERCA2b in mice (SERCA2b/b mice) results in only a moderate functional impairment, whereas SERCA activity is decreased
by a 40% lower SERCA protein expression and by increased inhibition by phospholamban. To find out whether the documented
kinetic differences in SERCA2b relative to SERCA2a (i.e., a twofold higher apparent Ca2þ affinity, but twofold lower maximal
turnover rate) can explain these compensatory changes, we simulated Ca2þ dynamics in mouse ventricular myocytes. The
model shows that the relative Ca2þ transport capacity of SERCA2a and SERCA2b depends on the SERCA concentration.
The simulations point to a dominant effect of SERCA2b’s higher Ca2þ affinity over its lower maximal turnover rate. The results
suggest that increased systolic and decreased diastolic Ca2þ levels in unstimulated conditions could contribute to the downre-
gulation of SERCA in SERCA2b/b mice. In stress conditions, Ca2þ handling is less efficient by SERCA2b than by SERCA2a,
which might contribute to the observed hypertrophy in SERCA2b/b mice. Altogether, SERCA2a might be a better compromise
between performance in basal conditions and performance during b-adrenergic stress.INTRODUCTIONThe transient release of Ca2þ from the sarcoplasmic retic-
ulum (SR) couples activation to contraction in skeletal
and cardiac muscle. The state of filling of the SR with
Ca2þ is thus an important factor in determining contractile
strength. Ca2þ loading of the SR is catalyzed by SERCA
Ca2þ-transport ATPases, which pump Ca2þ back into the
SR after its release, thereby contributing for ~50–90% to
the termination of the Ca2þ transient in mammalian ventric-
ular myocytes (1). In addition, SERCA-mediated Ca2þ
transport plays a central role in the b-adrenergic regulation
of the heart via interaction with the accessory membrane
protein phospholamban (2). Phosphorylation of phospho-
lamban during b-adrenergic stress releases its inhibitory
interaction, resulting in faster relaxation, augmented
loading of the SR with Ca2þ, and stronger contraction.
Alterations in SERCA’s Ca2þ pumping activity also play
a central role in heart pathology. A decline in the Ca2þ
load of the SR caused by decreased affinity of SERCA for
Ca2þ or by decreased SERCA levels is often associated
with heart failure, whereas Ca2þ overload of the SR can
cause arrhythmia (3–6).
Although in the heart, slow skeletal muscle, and to some
extent smooth muscle, express the SERCA2a splice variant,
all other cell types predominantly make use of SERCA2b,
which is considered the housekeeping isoform. This differ-
ential distribution suggests that SERCA2a is better adapted
to function in cells like striated muscle cells, which
generate faster Ca2þ transients than most other cell types.Submitted June 3, 2010, and accepted for publication January 14, 2011.
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0006-3495/11/03/1216/10 $2.00This raises the question of the functional link between
the characteristics of cellular Ca2þ dynamics and those of
the reticular Ca2þ pumps. SERCA2b differs functionally
from SERCA2a in its twofold higher affinity for cytosolic
Ca2þ and its approximately twofold lower maximal turn-
over rate (7,8). The physiological meaning of these charac-
teristics was explored in the SERCA2b/b mouse model. In
these genetically modified mice, the formation of the SER-
CA2a splice variant is prevented and splicing to the default
SERCA2b form is favored. A remarkable finding is that
these interventions result in a drop of the SERCA levels
to ~60% of wild-type. Moreover, expression of the SERCA
inhibitory protein phospholamban is increased, and phos-
phorylation of phospholamban, which removes the
protein’s inhibitory effect on SERCA, is decreased (9).
Although the animals develop cardiac hypertrophy, Ca2þ
transients in isolated ventricular cells appear normal except
when challenged with higher Ca2þ loads (10). Altogether,
this phenotype suggests that in the mouse heart, the higher
affinity of SERCA2b for Ca2þ represents a more critical
parameter than its lower maximal speed. An increased
activity of the SERCA pump below 0.1 mM concentration
of cytosolic Ca2þ is apparently not well tolerated in the
heart, resulting in downregulation of SERCA expression
and upregulation of inhibitory phospholamban. This inter-
pretation is further supported by various crosses of the
SERCA2b/b mice with SERCA2b transgenes. Inducing
a further increase of the Ca2þ affinity by crossing with
phospholamban knockout animals results in further down-
regulation of the SERCA2b level to about one-third of
the wild-type without severely impacting basal Ca2þ
handling (11). Conversely, enforced expression ofdoi: 10.1016/j.bpj.2011.01.024
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SERCA Kinetics and Cardiac Ca2þ Dynamics 1217SERCA2b obtained in crosses with SERCA2b transgenes
was compensated by an increased inhibition by phospho-
lamban (12).
To better understand the consequences of the enforced
SERCA2a-to-SERCA2b switch in mouse cardiac myocytes,
we designed a computer model of the intervention that takes
into consideration the presently known kinetic differences
between the two isoforms. This model includes information
about differences in rate constants of specific substeps of the
SERCA2 catalytic cycle.C
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FIGURE 1 Reaction scheme of the SERCA pump and its equilibrium
behavior. (A) Seven-step Post-Albers-type reaction scheme of the SERCA
pump. (B) Ca2þ-activation curves of SERCA2a and SERCA2b obtained
from the seven-step SERCA model using the rate constants from
Table S1. S2a, SERCA2a; S2b, SERCA2b. (C) Dependence of the amount
of SERCA-bound Ca2þ on Ca2þ concentration.METHODS
Simulation of SERCA2a and SERCA2b activity
The different kinetic properties of Ca2þ transport by SERCA2a and
SERCA2b have been well documented (7,8,11,13). SERCA2b differs
from SERCA2a in its nearly twofold lower maximal turnover rate, its
approximately twofold higher affinity for cytosolic Ca2þ and the lower
sensitivity of its maximal turnover rate to inhibition by luminal Ca2þ
([Ca2þ]SR). In addition, Dode et al. (7) have identified different kinetics
of several specific partial reaction steps. Using the seven-step Post-
Albers-type schema (Fig. 1 A; the multistep scheme), the changes reside
in steps 3, 4, and 7, which were modified accordingly in the SERCA2b
scheme (Table S1 in the Supporting Material). Fig. 1 B shows the
Ca2þ dependence of the steady-state turnover rate of SERCA2a and SER-
CA2b, with [Ca2þ]SR set equal to [Ca
2þ]cyt. To obtain a sufficient shift of
the Ca2þ affinity, r2 was assigned a smaller value also, in accordance with
recent structural data suggesting a stabilization of E1Ca or E1 or both
(13). These documented modifications represent a stronger decrease of
reverse compared to forward rate constants, predicting that SERCA2b
is able to build a steeper Ca2þ gradient over the SR membrane
(Fig. S1). However, the kinetic scheme predicts that at lower [Ca2þ]SR
that moderately decrease SERCA activity, SERCA2b is more easily in-
hibited due to the lower value of k7 (Fig. S2). This property makes it
more difficult to model the experimental data on the SERCA2b/b mouse,
which suggest a higher over-all Ca
2þ
transport rate for SERCA2b. It is
possible that other unidentified differences exist in SERCA2b at the level
of the luminal Ca2þ-binding sites that alleviate this higher sensitivity to
inhibition by luminal Ca2þ, but such hypothetical modifications were
not tested.
In addition to the seven-step Post-Albers-type cycle, we also used a single
equation to represent SERCA activity (denoted as the one-step scheme) that
captures the transport rate of the multistep scheme under conditions of
constant [Ca2þ]cyt and nonjunctional SR calcium concentration
([Ca2þ]NSR) (see Supporting Material).
In ventricular myocytes, the SERCA level differs between animal
species and correlates with the heart rate in mammals (1). In the faster-
beating heart of small animals like rats (~350 beats/min), it can reach
up to 50 mmol/kg (14). In mice (600 beats/min), the SERCA level
required to account for the relaxation rate is even higher. In our models,
and with a Vmax of ~30 s
1, a SERCA2a concentration of several tens of
mM/liter cell volume was required to obtain proper relaxation rates (see
Results).Whole-cell Ca2D dynamics model with
a homogeneous cytosolic compartment (cell
model)
This simple model considers two cellular compartments, the SR, with
a Ca2þ pump and a Ca2þ-release channel, and the cytosol (Fig. 2 A). SR
and cytosol are both treated as homogeneous. Ca2þ binding to calsequestrinin the SR is instantaneous. Ca2þ binding to troponin C (TRPN) is
described by
d½TRPNCa
dt
¼ ½TRPNtotal  TRPNCa 

Ca2þ

cyt
 kton  ½TRPNCa  ktoff :
(1)
Two different values were used for the off-rate constant of the Ca-troponin
complex to obtain sufficiently strong binding to troponin during systole
(ktoffsys, 25 s
1) and sufficiently fast unbinding during diastole (ktoffdia,
50 s1). An increase of ktoff during the shortening phase of the heartbeat
is in accordance with physiological data and is known as shortening deac-
tivation (see Edman (15) and Hinken and Solaro (16) for review). The tran-
sitions between both ktoff values occurred linearly with time, between 20
and 60 ms (ktoffsys to ktoffdia), and between 60 ms and the end of the beat
(ktoffdia to ktoffsys).
Since this model is only used to illustrate the implications of the SERCA
model on Ca2þ dynamics during a single beat, Ca2þ influx and efflux are
omitted. Parameters are given in Table S2.Biophysical Journal 100(5) 1216–1225
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FIGURE 2 Outline of the models used in the simulations. (A) The cell
model. The cytosol is considered as a homogeneous compartment. Since
this model is used only to simulate one isolated Ca2þ transient, Ca2þ influx
and efflux are omitted. (B) Geometry of a half-sarcomere in the sarcomere
model (not to scale). The region between the Z- and M-disks is divided into
five concentric compartments of 0.1-mm thickness surrounded by a contrac-
tile filament-free sheet of 0.25 mm. The longitudinal direction is divided
into 10 compartments of 0.1 mm each, all of which contain calmodulin
and ATP and seven of which contain troponin C (shaded region). Ca2þ is
released from the JSR into the two peripheral volumes closest to the
Z-disk. SERCAs translocate Ca2þ from the outer compartments of
segments 3–10 into the nonjunctional SR (NSR). Ca2þ efflux occurs from
all peripheral compartments.
1218 Raeymaekers et al.The rate of change of the Ca2þ concentration of the cytosolic compart-
ment due to activity of the SERCA multistep scheme is calculated accord-
ing to
d

Caþ

cyt
dt
¼ ½E1  Ca2þ
cyt
 k2 þ ½E1Ca
 Ca2þ
cyt
 k3  ½E1Ca  r2
 ½E1P2Ca  r3

: (2)
The rate of change of the free Ca2þ concentration in the SR induced by
the SERCA multistep scheme is represented byd½CaSR
dt
¼
 ½E2P  Ca2þ
SR
 r6  ½E2PCa 

Ca2þ

SR
 r5 þ ½E2P2Ca  k5 þ ½E2PCa  k6
  Volcyt
VolSR
1þ CSQNmax  CSQNKd
1þ CSQNK0:5
Ca2þ

SR
2
 Ca2þ
SR
: (3)CSQNmax represents the maximum Ca2þ-binding capacity of the SR and
CSQNKd the dissociation constant for luminal Ca
2þ binding.
When using the one-step SERCA representation, Eq. 2 and the Ca2þ flux
part of Eq. 3 were replaced by the appropriate relations, as described in the
previous section.Biophysical Journal 100(5) 1216–1225Changes of Ca2þ concentrations due to Ca2þ release from the SR are
given by
d

Ca2þ

SR
dt
¼ krelease
½CaJSR½Cacyt
¼
d

Ca2þ

cyt
dt
VolSR
Volcyt
: (4)
The rate constant krelease depends on time. krelease rises linearly with time
during 5 ms, from zero to a peak value (krelMax) of 180 s
1, and then
decreases linearly to zero, also in 5 ms.The compartmentalized sarcomere model
(sarcomere model)
The geometry and position of the various Ca2þ fluxes are indicated in
Fig. 2 B. The SR is considered continuous around the myofibril,
preserving symmetry and reducing computation time (17). Parameter
values are given in Table S3. Parameters and computations are the same
as for the cell model, except for the additional elements given below.
The program is run until a stable state is reached, defined as a <104%
change of the maximal level of troponin-bound Ca2þ between two consec-
utive beats.
To obtain a reasonable fast rate of Ca2þ diffusion, binding of Ca2þ to
ATP and simultaneous diffusion of Ca2þ-ATP were included (18). The
flux due to diffusion between two compartments is calculated from the
diffusion coefficient (D), the contact area (A), the concentration difference
(DC) and the distance separating the centers of the compartments (Dx) by
a numerical approximation of Fick’s law:
Flux ¼ A  D  DC=Dx: (5)
Ca2þ influx lasts for the first 10 ms of the beat, is constant with time, and
is inhibited by the calcium concentration in the junctional SR ([Ca2þ]JSR)
according to
Influx ¼ InflMax
1þ

Ca2þ

JSR
0:5
1:5: (6)
(concentrations in mM). Maximal Ca2þ influx, InflMax, is set at a value
such that it accounts for ~10% of the total Ca2þ entering the sarcomere
during regular pacing at 9 Hz in unstimulated conditions, as observed in
cardiac cells of small mammals (1). In addition to this activating Ca2þ
influx, there is a continuous background influx in longitudinal segments
1–7 amounting to 7.2 mM s1 in total.
The rate of Ca2þ efflux depends on the free Ca2þ concentration in the
superficial subcompartment Sx ([Ca]Sx) according tod½CaSx
dt
¼  ðEVÞmax
1þ
ðEKÞ0:5
½CacSx
: (7)
SERCA Kinetics and Cardiac Ca2þ Dynamics 1219Since Ca2þ efflux mainly occurs via the Naþ/Ca2þ exchanger, which
starts to operate in the forward mode only at a sufficiently polarized
membrane potential, Ca2þ efflux was switched off during the initial period
of each beat, set at 12 ms.
For convenience, an apparent rate constant of Ca2þ release was used that
applies to the change of the total JSR Ca2þ content instead of [Ca2þ]JSR.
This apparent rate constant, krelease, depends on time and increases with
increasing [Ca2þ]JSR to simulate the potentiating effect of SR Ca
2þ load
on the release (19). The time-dependent component (krelease,time) rises line-
arly with time during 5 ms from zero to a peak value (krelMax) of 6600 L s
1
and then decreases linearly to zero, also in 5 ms. krelMax corresponds to
a rate constant of 450 s1 at a [Ca2þ]JSR of 0.5 mM. krelease is given by
(concentrations in mM)
krelease ¼ krelease;time 1
1þ 0:5½CaJSR
; (8)
The maximum rate constant of Ca2þ leak from the JSR and NSR was set at
0.33 L s1 and dependent on [Ca2þ]JSR as in Eq. 8.
The change of the Ca2þ concentration in the peripheral compartments
and in the NSR due to SERCA activity was calculated either as a single-
state SERCA representation or as a multistate SERCA scheme.
Transfer of Ca2þ between the JSR and NSR is governed by the rate
constant ktrans:
d½CaJSR
dt
¼ ktrans
½CaJSR½CaNSR
¼ d½CaNSR
dt
VolJSR
VolNSR
: (9)
The models were programmed in Delphi (Borland Software, Austin, TX)
using the basic Euler method and run with constant time steps of 0.001 ms.
To exclude possible errors arising from the discreteness of the time steps
that may artifactually induce differences between models incorporating
SERCA2a or SERCA2b, results were compared between runs with and
runs without bookkeeping of total Ca2þ of the system, based on the inte-
grated amount of Ca2þ influx and Ca2þ efflux. When the program was
run with regular pacing until steady state (typically 100–300 beats), dia-
stolic and peak systolic levels of troponin-bound Ca2þ differed at most
by ~0.03%. These small values demonstrate that the effect of various
SERCA kinetic schemes cannot be explained by the accumulation of
computing errors.FIGURE 3 Simulation of a single beat in the cell model. Various SERCA
schemes result in different peak values of troponin-bound Ca2þ transients.RESULTS
The effect of various SERCA representations
on myofilament activation during a single beat
in the cell model
Ca2þ binds not only to troponin C, determining the degree
of myofilament contraction, but also to SERCA before its
complete translocation across the SR membrane. Thus,
troponin C and SERCA compete for Ca2þ binding, influ-
encing the amount of Ca2þ available for contraction. Multi-
state schemes take this into account and predict a faster rate
of Ca2þ removal from the cytosol in the early phase of the
Ca2þ transient than does the one-step Hill-type equation.
Consequently, in such a model, a smaller fraction of all
Ca2þ that enters the sarcomere will bind to the contractile
filaments, predicting a reduced contraction. The implica-
tions for a single isolated Ca2þ transient, starting from thesame initial conditions ([Ca2þ]cyt ¼ 0.08 mM, [Ca2þ]SR ¼
0.5 mM), are shown in Fig. 3 for a model that considers
the cytosol as a homogeneous compartment (cell model).
The amount of Ca2þ release was adjusted such that it caused
a peak level of ~60% average saturation of troponin at
a SERCA concentration of 40 mM using the SERCA2a
multistep scheme. This value corresponds to 26 mM
troponin-bound Ca2þ above the diastolic level (assuming
0.1 mM free Ca2þ), close to the accepted value of ~27 mM
for rabbit myocytes (3). With the one-step SERCA2a
models, a much higher peak level of troponin-bound Ca2þ
is reached (42.2 mM compared to 28.2 mM (Table 1)). The
calculated amount of Ca2þ that rapidly binds to SERCA
also differs between SERCA2a and SERCA2b (Fig. 3 and
Table 1). For example, at peak levels of calcium saturation,
48.7% of all Ca2þ released is bound to SERCA2a (multi-
step) compared to 43.3% for SERCA2b. This difference
can be explained by differences in kinetics of Ca2þ binding
during the rising phase of the Ca2þ transient and by the
difference in steady-state Ca2þ affinity: as is clear from
Fig. 1 C, additional Ca2þ binding by SERCA2b above that
by SERCA2a is higher at low Ca2þ levels than at high
concentrations, leaving less room for extra Ca2þ binding
during systole.
The simulations above show that the time course of the
changes of [Ca2þ]cyt at the level of troponin C relative to
that near the SERCA pumps may have implications for
the effects of the SERCA2a-to SERCA2b switch.Ca2D transients during a single beat
in the sarcomere model
To more faithfully reproduce the time course of the Ca2þ
concentration changes near the Ca2þ pumps, we used the
sarcomere model, which takes into account diffusion delays
between the Ca2þ release sites, the cytosolic Ca2þ buffers,
and the SR.Biophysical Journal 100(5) 1216–1225
TABLE 1 Systolic Ca2D pools (one single beat)
Multistep One-step
S2a S2b S2a S2b
DPeak Ca-troponin (mM)
Cell model 28.2 31.1 42.2 45.0
Sarcomere model 27.6 28.8 35.0 37.4
DPeak Ca-SERCA (mM)
Cell model 26.8 23.8
Sarcomere model 19.8 18.4
SERCA-bound Ca, % of total
Cell model 48.7 43.3
Sarcomere model 41.8 39.0
Distribution of bound Ca2þ over troponin and SERCA at the peak systolic
level during a single isolated beat starting from identical initial conditions
([Ca2þ]cyt¼ 0.08 mM, [Ca2þ]SR¼ 0.5 mM), compared between the cell and
sarcomere models and between SERCA2a and SERCA2b. Troponin-bound
Ca2þ and SERCA-bound Ca2þ are represented as the difference between
systolic and diastolic levels (DPeak) in absolute concentration, and for
SERCA-bound Ca2þ also as the percentage of total bound Ca2þ.
1220 Raeymaekers et al.Fig. 4 A shows the temporal and spatial distribution of
troponin-bound Ca2þ during a single beat in the sarcomere
model incorporating SERCA2a. Ca2þ is rapidly bound to
troponin in the segments close to the Z-disk. In the more
central segments of the sarcomere, there is a short delay
and the peak level is considerably lower. In cardiac muscle,
intrasarcomeric Ca2þ gradients can be expected to be
higher than in fast skeletal muscle, because in the latter,
Ca2þ is released at sites located closer to the center of
the sarcomere. Significant Ca2þ gradients within sarco-
meres of cardiac cells have also been observed experimen-
tally (20).
Troponin-bound Ca2þ of the transient shown in Fig. 4 A
averaged over the whole sarcomere is shown in Fig. 4 B
(solid line). This transient started from the same initial
conditions as the transient in the cell model in the previous
section (Fig. 3), and with a similar amplitude. As in the cell
model, the peak level of troponin-bound Ca2þ in the sarco-
mere model differs between multistep and one-step SERCA
schemes and between SERCA2a and SERCA2b. However,
the differences are smaller compared to the cell model
(Table 1), which can be explained by a relatively slower
rise of Ca2þ close to the SERCA pumps. Compared to the
cell model, the difference in the peak troponin-bound
Ca2þ between the SERCA2a multistep and one-step
schemes was reduced from 42.2  28.2 ¼ 14 to 35 
27.6 ¼ 7.4 mM. The difference caused by the SERCA2a-
to-SERCA2b switch was reduced from 4.9 (33.1 
28.2 mM) to 1.2 mM (28.8  27.6). Also, the fraction of
the released Ca2þ that rapidly binds to SERCA2a (repre-
sented as the multistep scheme) is reduced from 48.7% to
41.8%. The respective values for SERCA2b were 43.3 and
39% (Table 1). Thus, the sarcomere model favors Ca2þ
binding to troponin by reducing the time of diffusion of
Ca2þ toward the filaments relative to that toward the SR,
which results in less futile Ca2þ cycling.Biophysical Journal 100(5) 1216–1225In the initial phase of the Ca2þ reuptake, Ca2þ rise in the
SR lumen is about equally fast for SERCA2a and SERCA2b
(Fig. 4 C), which points to the lower Vmax of SERCA2b
having a less significant role than expected. In the later
phase, when [Ca2þ]cyt is low, Ca
2þ transport by SERCA2b
is slightly faster due to its higher Ca2þ affinity, resulting
in an overall higher total Ca2þ-transport activity. With
SERCA2b, a high level of troponin-bound Ca2þ is main-
tained for a longer time, thus prolonging contraction (early
phase). However, this prolonged activation occurs with pres-
ervation of low diastolic levels, even below control levels
(later phase) (Fig. 4 B). This is further illustrated in
Fig. 4 E, which shows the time-integrated amount of Ca2þ
removed from the cytosol, that is, the sum of Ca2þ translo-
cated across the SR membrane into the lumen and Ca2þ
bound to SERCA that is in surplus of the end-diastolic level.
Ca2þ buffering by the multistep SERCA schemes is visible
as the fast rise in the initial phase of the beat, which is
slightly faster for SERCA2a than for SERCA2b (see also
Fig. 4 D). The curves clearly show the faster Ca2þ translo-
cation by SERCA2b in the later phase of the Ca2þ transient.
This difference becomes more clear with time after the stim-
ulus, resulting in a higher SR Ca2þ load in a resting cell
(Fig. S3). Thus, these simulations show that in a single
beat, Ca2þ availability for contraction could be more effi-
cient in the presence of SERCA2b than in the presence of
SERCA2a, an unexpected finding.
It should be noted that the differences in the amplitude of
the Ca2þ transient caused by the SERCA2a-to-SERCA2b
switch in the multistep and one-step schemes should be
attributed to different, although somewhat related, explana-
tions: the enhanced transient in the presence of SERCA2b is
due to the lower Vmax in the one-step model, whereas it is
mainly caused by the lower Ca2þ buffering in the multistep
scheme.Ca2D transients of the sarcomere model during
regular pacing
To test whether the previous observations are also valid in
conditions of regular pacing, the sarcomere model was run
at specific stimulation frequencies till the output was stable.
In a first set of simulations, the SERCA concentration was
varied (Fig. 5). Changing the SERCA level between 20
and 100 mM has a relatively mild effect, especially on the
peak level of troponin-bound Ca2þ, demonstrating a strong
autoregulatory effect. This result can be explained by the
observation that decreased Ca2þ buffering by the pump
compensates for the decreased Ca2þ transport. In line with
this interpretation, the replacement of SERCA2a by
SERCA2b, the latter presenting less Ca2þ-buffering
capacity, causes a higher peak level, and this increase is
more pronounced with increasing SERCA concentration.
Transients of troponin-bound Ca2þ at 8 Hz pacing and the
effect of equimolar replacement of SERCA2a by SERCA2b
FIGURE 4 Examples of the dynamics of a single
beat in the sarcomere model. (A) Change of
troponin-bound Ca2þ in space and time in the pres-
ence of SERCA2a. In each segment in the x direc-
tion (distance from Z-disk (Fig. 2 B)), the
concentration of troponin-bound Ca2þ was aver-
aged over the five concentric rings subdividing
the segment. (B) Time course of troponin-bound
Ca2þ averaged over the whole sarcomere, using
the SERCA multistep or one-step representation.
(C) Time course of the luminal Ca2þ concentration
in the JSR and NSR in the presence of SERCA2a
or SERCA2b. (Inset) Initial phase for the SERCA
one-step equations. (D) Time course of the change
of SERCA-bound Ca2þ. The dotted line shows
Ca2þ bound to SERCA2b shifted down to the
same level as SERCA2a (solid line) at time zero.
(E) Integrated amount of Ca2þ removed from the
cytosol by various SERCA schemes starting from
the initiation of the Ca2þ transient at time zero.
SERCA Kinetics and Cardiac Ca2þ Dynamics 1221are shown in Fig. 6 A. As in the simulations of one single
transient, the peak amplitude is slightly enhanced by the
isoform switch, and the Ca2þ-bound state of troponin is
prolonged. The enhanced amplitude cannot be explained
by an increased loading of the SR with Ca2þ, because
[Ca2þ]SR is slightly lower with SERCA2b (Fig. 6 B).
It also cannot be explained by Ca2þ release on top of
an elevated end-diastolic Ca2þ. To the contrary, diastolic
Ca2þ is significantly decreased (Fig. 6, A and D). The
higher peak level is explained by the lower fast Ca2þ buff-
ering by SERCA2b, as demonstrated in previous sections.
Ca2þ transients are higher with the one-step SERCA
schemes, but the relative difference between SERCA2a
and SERCA2b in peak amplitude is preserved. The prolon-
gation of the duration of the transient is somewhat more
pronounced.
Data on the frequency dependency of the SERCA2a to
SERCA2b switch at 40 mM SERCA concentration are illus-
trated in Fig. 6, C and D. As expected, since a lowerfrequency prolongs the diastolic phase of low [Ca2þ]cyt,
where SERCA2b is more effective, the relative performance
of SERCA2b improves with decreasing frequency. This
difference is accounted for by the higher loading state of
the SR in the presence of SERCA2b (not shown).
To model cardiac cells of the SERCA2b/b mouse in which
the SERCA2 concentration is reduced to ~60% of the wild-
type level, SERCA2b concentrations of 40 and 24 mM
were compared. The peak of the Ca2þ transient is only
slightly shifted (Fig. 6 C). Diastolic levels of [Ca2þ]cyt are
lower in the presence of 24 mM SERCA2b at a frequency
of 6 Hz or lower, but increase at higher frequencies
(Fig. 6 D).
Although at 8 Hz the peak amplitude of troponin-bound
Ca2þ is slightly enhanced by an equimolar switch from
SERCA2a to SERCA2b (Fig. 6, A and C), it should be noted
that the pump function of the heart can be expected to be
more significantly increased due to lower end-diastolic
Ca2þ and because of the prolongation of the Ca2þ-boundBiophysical Journal 100(5) 1216–1225
FIGURE 5 Effect of SERCA concentration on peak systolic and diastolic
levels of troponin-bound Ca2þ at 6- and 8-Hz pacing and for SERCA2a and
SERCA2b multistep kinetic schemes.
1222 Raeymaekers et al.state of troponin (Fig. 6 A). The amount of troponin-bound
Ca2þ integrated over time starting from its peak systolic
level till it fell below 20 mM, a value well above diastolic
levels (Fig. 6 A), was 9.4% higher in the presence of
SERCA2b compared to SERCA2a, predicting a significant
impact on contractility.Simulations in stimulated conditions
Given the finding that SERCA2b, with a lower Vmax than
SERCA2a, is performing better at basal conditions, it is
plausible that the lower maximal activity of SERCA2b
only becomes limiting at higher Ca2þ concentrations.
Indeed, SERCA2b became less effective during strongerBiophysical Journal 100(5) 1216–1225activation of the contractile apparatus (Fig. 7). Stimulated
conditions were implemented by increasing Ca2þ influx
by 50% and by using a SERCA multistep model that yields
Ca2þ-activation curves with higher affinity (S2astim and
S2bstim (Table S1)), thus mimicking the effect of b-adren-
ergic stimulation via phosphorylation of L-type Ca2þ chan-
nels and phospholamban, respectively. Compared to the
unstimulated condition at 8 Hz, the peak level of Ca2þ-
bound troponin is increased by 10.6 mM with SERCA2a
and 7.3 mM with SERCA2b, resulting in lower systolic
levels and increased diastolic levels of Ca2þ-bound troponin
in SERCA2b cells. Lowering SERCA2b to 60% of control
further reduces the peak amplitude of Ca2þ-bound troponin
and increases the diastolic level, which is accompanied by
an increase of diastolic [Ca2þ]cyt from 62 nM (SERCA2a
60 mM, stimulated) to 79 nM (SERCA2b 36 mM, stimu-
lated). This increase could contribute to the observed hyper-
trophy, whereas the reduced peak amplitude could underlie
the impaired physiological stress test (11).DISCUSSION
Ca2D buffering by SERCA depends on the isoform
and on the simulation model
Compared to a one-step Hill equation, representing SERCA
activity by a Post-Albers kinetic scheme introduces several
additional degrees of freedom in the choice of parameters,
since the rate constants of each partial reaction steps are
not firmly established experimentally, especially at body
temperature. Thus, it is possible to change the values ofFIGURE 6 Behavior of the sarcomere model
during regular pacing in the presence of SERCA2a
or SERCA2b. (A) Time course of the change in
troponin-bound Ca2þ. (B) Time dependence of
the free Ca2þ concentration in the lumen of the
JSR. (C) Peak values of troponin-bound Ca2þ
during regular pacing at the indicated frequencies
until a stable state is achieved. (D) Frequency
dependence of end-diastolic [Ca2þ]cyt.
FIGURE 7 Ca2þ activation of troponin in stimulated conditions, using
SERCA schemes S2aStim and S2bStim (Table S1) and a 50% increase of
the Ca2þ influx.
SERCA Kinetics and Cardiac Ca2þ Dynamics 1223rate constants while preserving identical Ca2þ-activation
curves at equilibrium. The use of different sets of rate
constants has implications for the extent of fast Ca2þ buff-
ering, which in our scheme is moderate because of the
displacement of the E1-E2 equilibrium (step 1) toward E2.
The problem of the extensive Ca2þ buffering by SERCA
has been considered by the Baylor group in their mathemat-
ical models of Ca2þ transients in sarcomeres of frog and
mouse fast-twitch skeletal muscle (21,22). In considering
the energetic cost of a large amount of Ca2þ bypassing the
troponin C Ca2þ-binding sites, these authors have chosen
to incorporate additional states of SERCA1 with delayed
Ca2þ binding. There is indeed experimental evidence for
the existence of SERCA states that are dead-end complexes
of Ca2þ-free intermediates with Mg2þ and/or Hþ (23–25).
By choosing a slow transition rate from E1MgH toward
the unliganded E1 intermediate, Ca2þ binding to SERCA
is retarded during a sudden rise of the Ca2þ concentration,
such as during the rising phase of the Ca2þ transient. We
have not yet implemented these additional SERCA states
for several reasons. First, there is a paucity of kinetic data
on the transitions that could be involved, especially for
SERCA2. Second, in the mouse heart, the implications of
Ca2þ buffering by SERCA for the Ca2þ signal are expected
to be less severe than in fast-twitch skeletal muscle due to
the lower cardiac content of SERCA. Third, excessive
SERCA1a expression obtained by gene transfer leads to
impaired myocyte shortening that is adequately explained
by increased Ca2þ buffering by SERCA (26), indicating
that SERCA-related Ca2þ buffering indeed exists. The
cost of fast Ca2þ binding to SERCA could be offset by buff-
ering of the physiological effects of chronic changes of
SERCA activity, for example, by oxidative damage (27–
29). If SERCA levels were to respond to changes in cyto-
solic Ca2þ, the relatively small alteration of the Ca2þ
transient with changing SERCA concentrations, at least inthe high range of SERCA concentrations, suggests that the
SERCA level might be sensitive to subtle signals. However,
this outcome is not well supported by observations in mice
with decreased SERCA2 levels carrying a null mutation in
one copy of the SERCA2 gene (30), which show appre-
ciably reduced Ca2þ transients despite compensatory
changes in phospholamban phosphorylation and Naþ/
Ca2þ-exchange activity. This result would better fit with
a lower SERCA concentration, which, however, compli-
cates an explanation of the SERCA2b/b mouse model. On
the other hand, rapid cardiac-specific ablation of the
SERCA2 gene is initially well tolerated (31).The difference in pump activity between
SERCA2a and SERCA2b depends mainly
on the Ca2D affinity
SERCA2a has a twofold-higher catalytic turnover rate than
SERCA2b, but only half the Ca2þ affinity of SERCA2b.
Assuming that kinetic differences in Ca2þ transport have
prompted the selective expression of SERCA2a over
SERCA2b in cardiac cells, it would seem that the faster
maximal turnover of SERCA2a is more appropriate for
heart function than the higher Ca2þ affinity of SERCA2b,
i.e., the higher Ca2þ affinity of SERCA2b appears unlikely
to compensate for its lower turnover rate. However, several
findings on the SERCA2b/b mouse appear to contradict this
interpretation. In these gene-modified animals, an appar-
ently compensatory downregulation of cardiac SERCA2
levels and an increased inhibition of phospholamban are
seen. Both of these alterations result in less pump activity
at low cytosolic Ca2þ levels, suggesting that it is rather
the high Ca2þ affinity of SERCA2b that is not well toler-
ated. The simulations presented here support this hypothesis
for the mouse heart in unstimulated conditions. The better
performance of SERCA2b under low workload is seen
with both the one-step and multistep SERCA representa-
tions. This effect is explained in part by the lower competi-
tion of SERCA2b with the binding sites on troponin C, due
to the lower extent of fast Ca2þ buffering. The contribution
of SERCA buffering explains why the relative performance
of SERCA2b increases with increasing SERCA concentra-
tions entered into the model (Fig. 5). With our current
knowledge about the kinetic properties of SERCA2b and
the compensatory changes in the SERCA2b/b mouse, the
downregulation of SERCA in the transgenic animals can
best be explained if the normal SERCA level is ~40 mM
or higher. This concentration is well within the range
compatible with experimental observations (14).Limitations of the study
The simulations presented here are the result of a particular
choice of values for the model parameters, several of which
may have significant quantitative effects. In particular, theBiophysical Journal 100(5) 1216–1225
1224 Raeymaekers et al.value accepted for the degree of saturation of troponin with
Ca2þ during systole in the unstimulated heart, and the rela-
tive affinity of troponin C and SERCA for Ca2þ, can be
expected to be critical parameters affecting the relative
over-all transport capacity of the SERCA isoforms. As can
be expected intuitively, and also confirmed by the computer
simulations (not shown), relative SERCA2b performance
will increase with increasing Ca2þ affinity of the contractile
filaments because of the activation of the contractile appa-
ratus at lower average Ca2þ concentrations. All simulations
in basal conditions shown in this article apply to the condi-
tion of approximately equal Ca2þ affinities of SERCA2a
and troponin C during systole. Another important constraint
is the accepted systolic and diastolic levels of troponin-
bound Ca2þ.
Besides these troponin-related parameters, the concentra-
tion of SERCA and the characteristics of the Ca2þ efflux
determine the results of the model. Because of the large
contribution of Ca2þ buffering by SERCA and the different
buffering characteristics of SERCA2a and SERCA2b, the
SERCA concentration codetermines the outcome of the iso-
form replacement. The SERCA concentration required to
sustain a specific amplitude of the Ca2þ signal is also deter-
mined by the maximal turnover rate. This value is not firmly
established, in particular at body temperature. Furthermore,
as expected intuitively, the relative effectiveness of
SERCA2b increases with increasing rate of Ca2þ efflux in
the low Ca2þ range relative to the higher Ca2þ concentra-
tions (data not shown). When more quantitative information
on the in vivo parameters is obtained, the simulations and
their outcome may have to be adjusted accordingly.
Qualitatively, the better performance of SERCA2b, taking
into account the knownkinetic characteristics of this isoform,
is a robust result of the simulations. It should also be taken
into account that in the mutant mice, normal force can be
maintained with lower Ca2þ transients because of the hyper-
trophied state of the heart (9). However, the existence of addi-
tional, yet unknown differences between SERCA2a and
SERCA2b and unidentified compensatory or other changes
in the transgenic animals may contribute as well to the down-
regulation of SERCA in the SERCA2b/b mouse.Modeling supports a predominant role for
SERCA’s Ca2D affinity in basal conditions
Computer modeling has demonstrated that the major effects
of the SERCA2a-to-SERCA2b switch result in a slightly
higher peak level of the Ca2þ transient, a longer period of
activation of the filaments, and a lower end-diastolic Ca2þ
concentration in the unstimulated heart. This effect
increases with decreasing contraction strength, as shown
by the frequency dependence (Fig. 6, C and D) and by the
effects in stimulated conditions (Fig. 7). [Ca2þ]cyt is on
average lower in basal conditions than in the stimulated
heart, shifting the relative importance of the difference inBiophysical Journal 100(5) 1216–1225Vmax and K0.5 of SERCA2a and SERCA2b toward the
Ca2þ affinity. However, since the gain of function of
replacing SERCA2a by SERCA2b is not really
impressive, it remains a surprising observation that in the
SERCA2b/b mouse, SERCA levels are drastically reduced
to ~60% of wild-type, moreover in combination with an up-
regulation of inhibitory phospholamban levels. The simula-
tions presented here do not quantitatively account for this
strong reduction. At face value, the simulations indicate
that a factor contributing to the adjustment of the SERCA
levels could be the diastolic Ca2þ concentration in basal
conditions. Although normal systolic Ca2þ saturation of
troponin C is slightly lower with SERCA2b at 60% of
normal levels (Fig. 6 C), diastolic Ca2þ is below normal,
at least at frequencies of 6 Hz or lower (Fig. 6 D). In vivo,
it is likely that diastolic Ca2þ ends up at a higher level
because of the additional upregulation of the inhibition of
SERCA activity by phospholamban.
In stimulated conditions, the over-all Ca2þ-transport
capacity of SERCA2b relative to that of SERCA2a is
strongly reduced. This result is in line with experimental
observations on the SERCA2b/b mouse, which show that
the Ca2þ uptake by the SR is impaired at higher Ca2þ loads
only (10). SERCA2a might thus be a better compromise
between performance both in basal conditions and during
b-adrenergic stress. The model predicts an elevated diastolic
Ca2þ in SERCA2b/b myocytes in stressed conditions, which
may be a contributing factor to the observed hypertrophy
through activation of calcineurin.SUPPORTING MATERIAL
Three figures and three tables are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(11)00107-X.
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